Related references
Note: Only part of the references are listed.Thrombectomy in special populations: report of the Society of NeuroInterventional Surgery Standards and Guidelines Committee
Fawaz Al-Mufti et al.
JOURNAL OF NEUROINTERVENTIONAL SURGERY (2022)
Avatrombopag for chemotherapy-induced thrombocytopenia in patients with non-haematological malignancies: an international, randomised, double-blind, placebo-controlled, phase 3 trial
Hanny Al-Samkari et al.
Lancet Haematology (2022)
Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome The STOPDAPT-2 ACS Randomized Clinical Trial
Hirotoshi Watanabe et al.
JAMA CARDIOLOGY (2022)
Therapy of posttransplant poor graft function with eltrombopag
Khalid Halahleh et al.
BONE MARROW TRANSPLANTATION (2021)
A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumors and hematologic malignancies
Hanny Al-Samkari et al.
HAEMATOLOGICA (2021)
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Jean-Philippe Collet et al.
EUROPEAN HEART JOURNAL (2021)
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Gerhard Hindricks et al.
EUROPEAN HEART JOURNAL (2021)
Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta-analysis
Marco Valerio Mariani et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)
Effect of Baseline Thrombocytopenia on Long-Term Outcomes in Patients With Acute ST-Segment Elevated Myocardial Infarction - A Large Propensity Score-Matching Analysis From the China Acute Myocardial Infarction (CAMI) Registry -
Ru Liu et al.
CIRCULATION JOURNAL (2021)
HIGH-2-LOW risk model to predict venous thromboembolism in allogeneic transplant patients after platelet engraftment
Kylee L. Martens et al.
BLOOD ADVANCES (2021)
Cancer Therapy-Associated Thrombosis
Steven P. Grover et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)
The incidence of thrombocytopenia in adult patients receiving chemotherapy for solid tumors or hematologic malignancies
Jaime L. Shaw et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2021)
Anticoagulation in patients with atrial fibrillation, thrombocytopenia and hematological malignancy
Nir Livneh et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)
Challenges and Advances in Managing Thrombocytopenic Cancer Patients
Avi Leader et al.
JOURNAL OF CLINICAL MEDICINE (2021)
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer
Gary H. Lyman et al.
BLOOD ADVANCES (2021)
Thrombosis in immune thrombocytopenia - current status and future perspectives
Dawn Swan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Very Short Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients Who Underwent Complex Percutaneous Coronary Intervention Insight From the STOPDAPT-2 Trial
Ko Yamamoto et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2021)
Relative risk of arterial and venous thromboembolism in persons with cancer vs. persons without cancer-a nationwide analysis
Ella Grilz et al.
EUROPEAN HEART JOURNAL (2021)
Anticoagulation in cancer-associated thromboembolism with thrombocytopenia: a prospective, multicenter cohort study
Brian J. Carney et al.
BLOOD ADVANCES (2021)
Impact of Thrombocytopenia in Patients With Atrial Fibrillation Undergoing Left Atrial Appendage Occlusion: A Propensity-Matched Comparison of 190 Consecutive Watchman Implantations
Xiaochun Zhang et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Machine Learning-Augmented Propensity Score Analysis of Percutaneous Coronary Intervention in Over 30 Million Cancer and Non-cancer Patients
Dominique J. Monlezun et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Impact of anticoagulation on recurrent thrombosis and bleeding after hematopoietic cell transplantation
Kylee L. Martens et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)
Frank L. J. Visseren et al.
EUROPEAN HEART JOURNAL (2021)
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
Dawn O. Kleindorfer et al.
STROKE (2021)
Treatment of catheter-related thrombosis in patients with hematologic malignancies: A Venous thromboEmbolism Network US retrospective cohort study
Lisa Baumann Kreuziger et al.
THROMBOSIS RESEARCH (2021)
Risk of pulmonary emboli after removal of an upper extremity central catheter associated with a deep vein thrombosis
Damon E. Houghton et al.
BLOOD ADVANCES (2021)
Outcomes of Transradial Versus Transfemoral Access of Percutaneous Coronary Intervention in STEMI: Systematic Review and Updated Meta-analysis.
Yasar Sattar et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2021)
European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke
Eivind Berge et al.
EUROPEAN STROKE JOURNAL (2021)
Relative risk of arterial and venous thromboembolism in persons with cancer vs. persons without cancer-a nationwide analysis
Ella Grilz et al.
EUROPEAN HEART JOURNAL (2021)
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update
Michael Glikson et al.
EUROPACE (2020)
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Francesco Cosentino et al.
EUROPEAN HEART JOURNAL (2020)
2019 ESC Guidelines for the dignosis and management of acute pulmonary embolism development Toed in colaboration with the European Respiratory Society (ERS)
Stavros Konstantinides et al.
EUROPEAN HEART JOURNAL (2020)
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)
Juhani Knuuti et al.
EUROPEAN HEART JOURNAL (2020)
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
Nigel S. Key et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
The association between haemorrhage and markers of endothelial insufficiency and inflammation in patients with hypoproliferative thrombocytopenia: a cohort study
Paula F. Ypma et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Romiplostim in patients undergoing hematopoietic stem cell transplantation: results of a phase 1/2 multicenter trial
Regis Peffault de latour et al.
BLOOD (2020)
Clinical outcomes of isolated distal deep vein thrombosis versus proximal venous thromboembolism in cancer patients: The Cleveland Clinic experience
Shyam K. Poudel et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis
Frits Mulder et al.
BLOOD (2020)
Anticoagulation in thrombocytopenic patients with hematological malignancy: A multinational clinical vignette-based experiment
Avi Leader et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2020)
Outcomes after Vena Cava Filter Use in Patients with Cancer-Associated Venous Thromboembolism and Contraindications to Anticoagulation
Andres Quezada et al.
THROMBOSIS AND HAEMOSTASIS (2020)
Prevalence, predictors, and prognosis of symptomatic intracranial stenosis in patients with transient ischaemic attack or minor stroke: a population-based cohort study
Robert Hurford et al.
LANCET NEUROLOGY (2020)
Dual anti-platelet therapy following percutaneous coronary intervention in a population of patients with thrombocytopenia at baseline: a meta-analysis
Long Manyun et al.
BMC PHARMACOLOGY & TOXICOLOGY (2020)
Initial Invasive or Conservative Strategy for Stable Coronary Disease
David J. Maron et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Association of Inferior Vena Cava Filter Placement With Rates of Pulmonary Embolism in Patients With Cancer and Acute Lower Extremity Deep Venous Thrombosis
Samyuktha Balabhadra et al.
JAMA NETWORK OPEN (2020)
Venous thromboembolism in palliative care patients: what do we know?
Simon Noble
THROMBOSIS RESEARCH (2020)
Management of Patients with Acute Coronary Syndrome and Cancer
Tyler B. Moran et al.
CURRENT CARDIOLOGY REPORTS (2020)
Immature platelets: a review of the available evidence
Naoufal Benlachgar et al.
THROMBOSIS RESEARCH (2020)
Management and outcomes of cancer patients with venous thromboembolism presenting with thrombocytopenia
Ramon Lecumberri et al.
THROMBOSIS RESEARCH (2020)
One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk Patients
David E. Kandzari et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2020)
Risk and consequences of chemotherapy-induced thrombocytopenia in US clinical practice
Derek Weycker et al.
BMC CANCER (2019)
Eltrombopag for post-transplant cytopenias due to poor graft function
Serena Marotta et al.
BONE MARROW TRANSPLANTATION (2019)
Local Ultrasound-Facilitated Thrombolysis in High-Risk Pulmonary Embolism: First Dutch Experience
Maria A. de Winter et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2019)
Thrombocytopenia and declines in platelet counts: predictors of mortality and outcome after mechanical thrombectomy
Sebastian Moench et al.
JOURNAL OF NEUROLOGY (2019)
The efficacy and safety of a catheter removal only strategy for the treatment of PICC line thrombosis versus standard of care anticoagulation: a retrospective review
Joseph J. Shatzel et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2019)
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
Renato D. Lopes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
A. A. Khorana et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Prevalence, symptom burden, and natural history of deep vein thrombosis in people with advanced cancer in specialist palliative care units (HIDDen): a prospective longitudinal observational study
Clare White et al.
LANCET HAEMATOLOGY (2019)
Eltrombopag treatment during induction chemotherapy for acute myeloid leukaemia: a randomised, double-blind, phase 2 study
Noelle Frey et al.
LANCET HAEMATOLOGY (2019)
Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study
Noémie Kraaijpoel et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Cardiovascular and bleeding outcomes in a population-based cohort of patients with chronic immune thrombocytopenia
Kasper Adelborg et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Fibrinolysis in patients with chemotherapy-induced thrombocytopenia and the effect of platelet transfusion
Floor C. J. I. Heubel-Moenen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Anticoagulation of cancer patients with non-valvular atrial fibrillation receiving chemotherapy: Guidance from the SSC of the ISTH
Aurelien Delluc et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Disseminated Intravascular Coagulation in Cancer: An Update
Marcel Levi
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2019)
Effects of Baseline Thrombocytopenia on In-hospital Outcomes in Patients Undergoing Elective Percutaneous Coronary Intervention
Jun Shiraishi et al.
INTERNAL MEDICINE (2019)
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI The STOPDAPT-2 Randomized Clinical Trial
Hirotoshi Watanabe et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
Francois Mach et al.
ATHEROSCLEROSIS (2019)
Romiplostim Treatment of Chemotherapy-Induced Thrombocytopenia
Gerald A. Soff et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials
Yuesong Pan et al.
JAMA NEUROLOGY (2019)
Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients with Thrombocytopenia
Yifeng Yang et al.
CEREBROVASCULAR DISEASES (2019)
Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials
Giuseppe Gargiulo et al.
EUROPEAN HEART JOURNAL (2019)
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
Dominique Farge et al.
LANCET ONCOLOGY (2019)
Arterial thromboembolic events preceding the diagnosis of cancer in older persons
Babak B. Navi et al.
BLOOD (2019)
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
Marc Carrier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
Victor Aboyans et al.
EUROPEAN HEART JOURNAL (2018)
Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial
N. D. Yeomans et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
The Epidemiology and Clinical Associations of Stroke in Patients With Acute Myeloid Leukemia: A Review of 10,972 Admissions From the 2012 National Inpatient Sample
Christopher Del Prete et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2018)
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
Annie M. Young et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Charles A. Schiffer et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Management of cancer-associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH
B. T. Samuelson Bannow et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH
A. A. Khorana et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Comparative outcomes of thrombocytopenic acute leukemic patients with venous thromboembolism at a Comprehensive Cancer Center
Maliha Khan et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2018)
Incidence and outcomes of catheter related thrombosis (CRT) in patients with acute leukemia using a platelet-adjusted low molecular weight heparin regimen
Kay T. Htun et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2018)
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
Gary E. Raskob et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA
S. Claiborne Johnston et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
William J. Powers et al.
STROKE (2018)
Safety of Diagnostic and Therapeutic Cardiac Catheterization in Cancer Patients With Acute Coronary Syndrome and Chronic Thrombocytopenia
Cezar Iliescu et al.
AMERICAN JOURNAL OF CARDIOLOGY (2018)
Antithrombotic medication in cancer-associated thrombocytopenia: Current evidence and knowledge gaps
A. Leader et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Laterality is an Independent Predictor of Endovascular Thrombectomy in Patients With Low National Institute of Health Stroke Scale
Shashvat M. Desai et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2018)
Azacitidine with or without eltrombopag for first-line treatment of intermediate- or high-risk MDS with thrombocytopenia
Michael Dickinson et al.
BLOOD (2018)
A five-year, single-centre experience on ultrasound-assisted, catheter-directed thrombolysis in patients with pulmonary embolism at high risk and intermediate to high risk
Cihangir Kaymaz et al.
EUROINTERVENTION (2018)
Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials
Benjamin Scally et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation
Surbhi Shah et al.
BLOOD ADVANCES (2018)
Catheter-directed Thrombolysis for Intermediate-Risk Pulmonary Embolism
David Furfaro et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2018)
Management of anticoagulation for cancer-associated thrombosis in patients with thrombocytopenia: A systematic review
Bethany R. Samuelson Bannow et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2018)
Optimal Medical Therapy in Patients with Malignancy Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome: a BleeMACS Sub-Study
Mario Iannaccone et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2017)
Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis
Carlo Patrono et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Risk of Arterial Thromboembolism in Patients With Cancer
Babak B. Navi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Patients treated for acute VTE during periods of treatment-related thrombocytopenia have high rates of recurrent thrombosis and transfusion-related adverse outcomes
B. T. Samuelson Bannow et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2017)
Enoxaparin dose reduction for thrombocytopenia in patients with cancer: a quality assessment study
Simon Mantha et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2017)
Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohort
Damon E. Houghton et al.
LEUKEMIA & LYMPHOMA (2017)
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
J. W. Eikelboom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Aspirin Is Associated with Improved Survival in Severely Thrombocytopenic Cancer Patients with Acute Myocardial Infarction
Attila Feher et al.
ONCOLOGIST (2017)
Cancer and Venous Thromboembolic Disease: A Review
Eoin Donnellan et al.
ONCOLOGIST (2017)
Systemic Thrombolytic Therapy for Acute Pulmonary Embolism: Who Is a Candidate?
Stavros V. Konstantinides et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Identifying predictors for bleeding in hospitalized cancer patients: A cohort study
Rushad Patell et al.
THROMBOSIS RESEARCH (2017)
Catheter-directed, ultrasound-assisted thrombolysis is a safe and effective treatment for pulmonary embolism, even in high-risk patients
Kristen A. Lee et al.
JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS (2017)
Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial
Esther N. Oliva et al.
LANCET HAEMATOLOGY (2017)
Management and outcomes of patients with atrial fibrillation and a history of cancer: the ORBIT-AF registry
Chiara Melloni et al.
EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2017)
Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study
Raymond S. M. Wong et al.
BLOOD (2017)
Laboratory predictors of bleeding and the effect of platelet and RBC transfusions on bleeding outcomes in the PLADO trial
Lynne Uhl et al.
BLOOD (2017)
Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Previous Major Gastrointestinal Bleeding (from the Amplatzer Cardiac Plug Multicenter Registry)
Mathieu Lempereur et al.
AMERICAN JOURNAL OF CARDIOLOGY (2017)
Clopidogrel-Paclitaxel Drug-Drug Interaction: A Pharmacoepidemiologic Study
K. Agergaard et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Management of venous thromboembolism during thrombocytopenia after autologous hematopoietic cell transplantation
Ang Li et al.
BLOOD ADVANCES (2017)
Safety of Catheter-Directed Thrombolysis for Massive and Submassive Pulmonary Embolism: Results of a Multicenter Registry and Meta-Analysis
Tyler L. Bloomer et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2017)
Venous thromboembolism in patients with hematologic malignancy and thrombocytopenia
Nabin Khanal et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Eltrombopag for Treatment of Thrombocytopenia after Allogeneic Hematopoietic Cell Transplantation
Takashi Tanaka et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Effect of Baseline Thrombocytopenia on Ischemic Outcomes in Patients With Acute Coronary Syndromes Who Undergo Percutaneous Coronary Intervention
Mayank Yadav et al.
CANADIAN JOURNAL OF CARDIOLOGY (2016)
SCAI Expert consensus statement: Evaluation, management, and special considerations of cardio-oncology patients in the cardiac catheterization laboratory (endorsed by the cardiological society of india, and sociedad Latino Americana de Cardiologa intervencionista)
Cezar A. Iliescu et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2016)
Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel Report
Clive Kearon et al.
CHEST (2016)
Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry
Lucas V. A. Boersma et al.
EUROPEAN HEART JOURNAL (2016)
Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation
Joelle Kefer et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation
J. I. Zwicker et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial
Guillaume Cayla et al.
LANCET (2016)
Prediction of bleeding and prophylactic platelet transfusions in cancer patients with thrombocytopenia
Pernille J. Vinholt et al.
PLATELETS (2016)
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)
Massimo F. Piepoli et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2016)
Stent Thrombosis and Dual Antiplatelet Therapy Interruption With Everolimus-Eluting Stents Insights From the Xience V Coronary Stent System Trials
Philippe Genereux et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2015)
Risk of bleeding and use of platelet transfusions in patients with hematologic malignancies: recurrent event analysis
Simon J. Stanworth et al.
HAEMATOLOGICA (2015)
A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism The SEATTLE II Study
Gregory Piazza et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2015)
Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer A Randomized Clinical Trial
Agnes Y. Y. Lee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
2015 ACC/HRS/SCAI Left Atrial Appendage Occlusion Device Societal Overview
Frederick Masoudi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation A Patient-Level Meta-Analysis
David R. Holmes et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Zotarolimus-Eluting Versus Bare-Metal Stents in Uncertain Drug-Eluting Stent Candidates
Marco Valgimigli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Dual antiplatelet therapy in stroke and ICAS Subgroup analysis of CHANCE
Liping Liu et al.
NEUROLOGY (2015)
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
James D. Douketis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk
Philip Urban et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke
O. A. Berkhemer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure Substudy of the RE-LY trial
James D. Douketis et al.
THROMBOSIS AND HAEMOSTASIS (2015)
Risk of bleeding and use of platelet transfusions in patients with hematologic malignancies: recurrent event analysis
Simon J. Stanworth et al.
HAEMATOLOGICA (2015)
Management and outcomes of cancer-associated venous thromboembolism in patients with concomitant thrombocytopenia: a retrospective cohort study
Ilana Kopolovic et al.
ANNALS OF HEMATOLOGY (2015)
Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- The ATHENA study
Lise J. Estcourt et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Results of a Randomized, Double-Blind Study of Romiplostim Versus Placebo in Patients With Low/Intermediate-1-Risk Myelodysplastic Syndrome and Thrombocytopenia
Aristoteles Giagounidis et al.
CANCER (2014)
Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism
Nils Kucher et al.
CIRCULATION (2014)
Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy
David R. Holmes et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Catheter-associated deep vein thrombosis of the upper extremity in cancer patients: guidance from the SSC of the ISTH
J. I. Zwicker et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Percutaneous Left Atrial Appendage Closure for Stroke Prophylaxis in Patients With Atrial Fibrillation 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) Trial
Vivek Y. Reddy et al.
CIRCULATION (2013)
Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients
Jorge Labrador et al.
HAEMATOLOGICA (2013)
Thrombocytopenia and In-hospital Mortality Risk among Ischemic Stroke Patients
Jason J. Sico et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2013)
Left Atrial Appendage Closure With the Watchman Device in Patients With a Contraindication for Oral Anticoagulation The ASAP Study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology)
Vivek Y. Reddy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials
N. Bhala et al.
LANCET (2013)
Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack
Yongjun Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A No-Prophylaxis Platelet-Transfusion Strategy for Hematologic Cancers
Simon J. Stanworth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Cancer patients requiring interruption of long-term warfarin because of surgery or chemotherapy induced thrombocytopenia: The use of fixed sub-therapeutic doses of low-molecular weight heparin
Giorgia Saccullo et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopenia
Cassandra D. Josephson et al.
BLOOD (2012)
Executive Summary Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Gordon H. Guyatt et al.
CHEST (2012)
Treatment and Outcomes of Acute Coronary Syndrome in the Cancer Population
Syed Wamique Yusuf et al.
CLINICAL CARDIOLOGY (2012)
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial
Peter Sandercock et al.
LANCET (2012)
Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study
Hannes Wandt et al.
LANCET (2012)
Effects of Clopidogrel Added to Aspirin in Patients with Recent Lacunar Stroke
Oscar R. Benavente et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer
Giancarlo Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Bedside Monitoring to Adjust Antiplatelet Therapy for Coronary Stenting
Jean-Philippe Collet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Anticancer treatment and thrombosis
Anna Falanga et al.
THROMBOSIS RESEARCH (2012)
Impact of baseline thrombocytopenia on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty: Analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial
Diaa A. Hakim et al.
AMERICAN HEART JOURNAL (2011)
Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis
Marc I. Chimowitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Personalized Medicine, Pharmacogenetics, and Clopidogrel: Unraveling Variability of Response
Bianca Rocca et al.
MOLECULAR INTERVENTIONS (2010)
Incidence and Prognostic Significance of Thrombocytopenia Developed During Acute Coronary Syndrome in Contemporary Clinical Practice
Tracy Y. Wang et al.
CIRCULATION (2009)
Anemia and Thrombocytopenia in Patients Undergoing Chemotherapy for Solid Tumors: A Descriptive Study of a Large Outpatient Oncology Practice Database, 2000-2007
Ying Wu et al.
CLINICAL THERAPEUTICS (2009)
Predictors of Coronary Stent Thrombosis The Dutch Stent Thrombosis Registry
Jochem W. van Werkum et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
LANCET (2009)
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study
Giancarlo Agnelli et al.
LANCET ONCOLOGY (2009)
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
S. J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Safety and Efficacy of Endovascular Thrombectomy in Patients With Abnormal Hemostasis Pooled Analysis of the MERCI and Multi MERCI Trials
Raul G. Nogueira et al.
STROKE (2009)
Thrombocytopenia at baseline is a predictor of inhospital mortality in patients undergoing percutaneous coronary intervention
Christopher B. Overgaard et al.
AMERICAN HEART JOURNAL (2008)
Blood Transfusions, Thrombosis, and Mortality in Hospitalized Patients With Cancer
Alok A. Khorana et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin
Javier de la Serna et al.
BLOOD (2008)
The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention
David E. Gerber et al.
BLOOD (2008)
Mechanical thrombectomy for acute ischemic stroke - Final results of the multi MERCI trial
Wade S. Smith et al.
STROKE (2008)
Risk factor status and vascular events in patients with symptomatic intracranial stenosis
S. Chaturvedi et al.
NEUROLOGY (2007)
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Stephen D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Usefulness of checking platelet count before thrombolysis in acute ischemic stroke
Brett L. Cucchiara et al.
STROKE (2007)
Impact of aspirin therapy in cancer patients with thrombocytopenia and acute coronary syndromes
Mona G. Sarkiss et al.
CANCER (2007)
Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations
A. Lanas et al.
GUT (2006)
A descriptive analysis of international transfusion practice and bleeding outcomes in patients with acute leukemia
NM Heddle et al.
TRANSFUSION (2006)
Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer
AYY Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
P Prandoni et al.
BLOOD (2002)
Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparin
M Simon et al.
BONE MARROW TRANSPLANTATION (2001)
Incidence, cost, and outcomes of bleeding and chemotherapy dose modification among solid tumor patients with chemotherapy-induced thrombocytopenia
LS Elting et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
